SCHEMBL21035263

SCHEMBL21035263

c1ccc(-n2c3ccc(-c4ccc5c(c4)c4ccccc4c4c6ccccc6c6ccccc6c54)cc3c3ccc4ccccc4c32)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CYP1A2 P05177 4/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
HPRT1 P00492 4/20 0.34
MAPK1 P28482 1/20 0.33
ALDH1A1 P00352 3/20 0.33
THRB P10828 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PTGER4 P35408 1/20 0.32
PTGES O14684 1/20 0.32
FYN P06241 2/20 0.31
ACHE P22303 2/20 0.31
AHR P35869 2/20 0.31
ERBB2 P04626 1/20 0.31
MAOA P21397 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19131681 0.93 KDM4E (0.37) KDM4EATML3MBTL1CYP1A2CYP2C9
SCHEMBL19132476 0.93 HPRT1 (0.41) KDM4EATML3MBTL1CYP1A2CYP2C9
SCHEMBL19132343 0.91 HPRT1 (0.37) KDM4EATML3MBTL1CYP1A2CYP2C9
SCHEMBL19132154 0.91 KDM4E (0.40) KDM4EATML3MBTL1CYP1A2CYP2C9
SCHEMBL21190560 0.89 KDM4E (0.38) KDM4EATML3MBTL1CYP1A2CYP2C9
SCHEMBL17298652 0.89 L3MBTL1 (0.51) KDM4EATML3MBTL1HPRT1ALDH1A1
SCHEMBL19132481 0.88 KDM4E (0.41) KDM4EATML3MBTL1CYP1A2CYP2C9
SCHEMBL19131248 0.88 L3MBTL1 (0.50) KDM4EATML3MBTL1CYP1A2CYP2C9
SCHEMBL10041762 0.87 NR3C1 (0.39) KDM4EATML3MBTL1HPRT1KMT2A
SCHEMBL23741669 0.87 L3MBTL1 (0.44) KDM4EATML3MBTL1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190165279-A1 ORGANIC ELECTROLUMINESCENT ELEMENT JNC CORPORATION (JP) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190165279-A1 ORGANIC ELECTROLUMINESCENT ELEMENT TCF4, LGR4, OR51E2 KDM4E 396/4885ATM 1673/4885L3MBTL1 834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.